Enhancing the estimation of PaCO2 from etCO2 during ventilation through non-invasive parameters in the ovine model

被引:0
|
作者
Gruene, Mike [1 ,2 ]
Olivier, Lena [1 ]
Pfannschmidt, Valerie [2 ]
Huetten, Matthias [3 ]
Orlikowsky, Thorsten [1 ]
Stollenwerk, Andre [2 ]
Schoberer, Mark [1 ]
机构
[1] RWTH Aachen Univ Hosp, Dept Paediat & Adolescent Med, Aachen, Germany
[2] Rhein Westfal TH Aachen, Embedded Software-Informat 11, Aachen, Germany
[3] Maastricht Univ Med Ctr, MosaKids Childrens Hosp, Maastricht, Netherlands
关键词
Closed loop control; EtCO2; Mechanical ventilation; Neonates; PaCO2; Robust linear regression; Ventilation; PRETERM BIRTH; BLOOD-GAS; ARTERIAL; CHILDREN; INFANTS;
D O I
10.1186/s12938-024-01292-2
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background In mechanically ventilated neonates, the arterial partial pressure of CO2 (PaCO2) is an important indicator for the adequacy of ventilation settings. Determining the PaCO2 is commonly done using invasive blood gas analyses, which constitute risks for neonates and are typically only available infrequently. An accurate, reliable, and continuous estimation of PaCO2 is of high interest for medical staff, giving the possibility of a closer monitoring and faster reactions to changes. We aim to present a non-invasive estimation method for PaCO2 in neonates on the basis of end-tidal CO2 (etCO(2)) with inclusion of different physiological and ventilation parameters. The estimation method should be more accurate than an estimation by unaltered etCO(2) measurements with regard to the mean absolute error and the standard deviation. Methods Secondary data from 51 preterm lambs are used, due to its high comparability to preterm human data. We utilize robust linear regression on 863 PaCO2 measurements below or equal to 75 mmHg from the first day of life. etCO(2) along with a set of ventilation settings and measurements as well as vital parameters are included in the regression. Included independent variables are chosen iteratively by highest Pearson correlation to the remaining estimation deviation. Results The evaluation is carried out on 12 additional neonatal lambs with 246 PaCO2 measurements below or equal to 75 mmHg from the first two days of life. The estimation method shows a mean absolute error of 3.80 mmHg with a 4.92 mmHg standard deviation of differences and a standard error of 0.31 mmHg in comparison to measured PaCO2 by blood gas analysis. Conclusions The estimation of PaCO2 by the proposed equation is less biased than unaltered etCO(2). The usage of this method in clinical practice or in applications like the automation of ventilation needs further investigation.
引用
收藏
页数:14
相关论文
共 49 条
  • [41] Semi-quantitative cerebral blood flow parameters derived from non-invasive [15O]H2O PET studies
    Koopman, Thomas
    Yaqub, Maqsood
    Heijtel, Dennis F. R.
    Nederveen, Aart J.
    van Berckel, Bart N. M.
    Lammertsma, Adriaan A.
    Boellaard, Ronald
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 (01): : 163 - 172
  • [42] NON-INVASIVE ESTIMATION OF THE DEGREE OF REGURGITATION FROM TWO-DIMENSIONAL (2-D) DOPPLER-ECHO (FLOW-STRUCTURE) CARDIAC IMAGE
    KITABATAKE, A
    MASUYAMA, T
    ASAO, M
    TANOUCHI, J
    MORITA, T
    ITO, H
    HORI, M
    INOUE, M
    ABE, H
    CIRCULATION, 1983, 68 (04) : 367 - 367
  • [43] Monitoring of non-invasive absolute cerebral oxygen saturation (fore-sight technology) during induced changes in end-tidal CO2 (hyper-hypo-ventilation)
    De Deyne, Cathy S.
    De Burghgraeve, Francis
    De Sloovere, Veerle
    Jans, Frank
    Heylen, Rene
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 : S6 - S7
  • [44] Use of Non-invasive Parameters and Machine-Learning Algorithms for Predicting Future Risk of Type 2 Diabetes: A Retrospective Cohort Study of Health Data From Kuwait
    Farran, Bassam
    AlWotayan, Rihab
    Alkandari, Hessa
    Al-Abdulrazzaq, Delia
    Channanath, Arshad
    Thanaraj, Thangavel Alphonse
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [45] Outcome of Prophylactic Non-invasive Ventilation Following Planned Extubation in High-risk Patients: 2-year Prospective Observational Study from a General Intensive Care Unit
    Ghosh, Supradip
    Chawla, Aayush
    Jhalani, Ranupriya
    Salhotra, Ripenmeet
    Arora, Garima
    Nagar, Satyanarayan
    Bhadauria, Abhay S.
    Mishra, Kirtee
    Singh, Amandeep
    Lyall, Aditya
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (12) : 1185 - 1192
  • [46] P74 Non-invasive ventilation delivered on a standard respiratory unit compared to use in level 2 care setting: is there an ideal service delivery model? (vol 71, pg A125, 2016)
    Jayadev, A.
    Mcvinnie, K.
    Moonsie, I
    THORAX, 2017, 72 (03)
  • [47] Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation
    Duca, Andrea
    Memaj, Irdi
    Zanardi, Federico
    Preti, Carlo
    Alesi, Andrea
    Della Bella, Lorenzo
    Ghezzi, Elena
    Di Marco, Fabiano
    Lorini, Ferdinando Luca
    Venturelli, Serena
    Fagiuoli, Stefano
    Cosentini, Roberto
    ECLINICALMEDICINE, 2020, 24
  • [48] Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b/2a Clinical Trial Double-Blind (DB) with Open Label Extensions (OLE) [NCT02238626 ] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no-NIV) up to 5 Years (Early Cohort-EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 Years(Advanced NIV Cohort-ANC) from Disease Onset - Behavior of Creatinine as a Biomarker in Short Clinical Trials
    Brooks, Benjamin
    Bravver, Elena
    Sanjak, Mohammed
    Langford, Velma
    Graves, Donna
    Moore, Linda
    Lary, Cynthia
    Newell-Sturdivant, Allison
    Russo, Priscilla
    Burdette, Maryanne
    Lucas, Nicole
    Patterson, Charity
    Anderson, William
    Bockenek, William
    Desai, Urvi
    Lindblom, Scott
    Dojillo, Joanna
    Matsuda, Kazuko
    Iwaki, Yuichi
    NEUROLOGY, 2016, 86
  • [49] Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b / 2a Clinical Trial Double - Blind (DB) with Open Label Extension (OLE) [NCT02238626] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no NIV) up to 5 years (Early Cohort - EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 years (Advanced NIV Cohort - ANC) from Disease Onset - Report of Clinical Trial DB, OLE and Post-Treatment Cessation Epochs - Per-Protocol (PP) Treatment Completion Associated with Improved Survival and Post Treatment Cessation Loss of Muscle Strength
    Brooks, Benjamin Rix
    Bravver, Elena
    Sanjak, Mohammed
    Langford, Velma
    Moore, Linda
    Smith, Nicole
    Lucas, Nicole
    Nichols, Mindy
    Lary, Cynthia
    Newell-Sturdivant, Allison
    Nemeth, Joanne
    Russo, Priscilla
    Brandon, Nicol
    Ranzinger, Lisa
    Burdette, Maryanne
    Wright, Kathryn
    Ward, Amber
    Holsten, Scott
    Fischer, Michael
    Hillberry, Rachel
    Bockenek, William
    Lindblom, Scott S.
    Bringardner, Benjamin
    Sachar, David
    Dojillo, Joanna
    Matsuda, Kazuko
    Iwaki, Yuichi
    NEUROLOGY, 2017, 88